JeffreyDeanAlexisMD
Cardiology • Rochester, NYAdult Congenital Heart Disease, Heart Failure & Transplantation
Associate Professor, Medicine, University of Rochester School of Medicine & Dentistry
Dr. Alexis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Box 679b
Rochester, NY 14642Phone+1 585-276-9761Fax+1 585-427-8718
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 1995 - 1998
Massachusetts General HospitalResidency, Internal Medicine, 1992 - 1995
Harvard Medical SchoolClass of 1992
Certifications & Licensure
NY State Medical License 1995 - 2025
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FACC) American College of Cardiology
Clinical Trials
- The ARIES HeartMate 3 Pump IDE Study Start of enrollment: 2020 Jul 14
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Survival and Readmission Burden in Advanced Heart Failure Patients Managed With Ventricular Assist Device Versus Continued Medical Therapy.Jeffrey D Alexis, Katherine Wood, Igor Gosev, Anas Jawaid, Leway Chen
ASAIO Journal. 2025-03-03 - Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure.Ilan Goldenberg, Justin Ezekowitz, Christine Albert, Jeffrey D Alexis, Lisa Anderson
Heart Rhythm. 2025-01-27 - Reassessing the need for primary prevention implantable cardioverter-defibrillators in contemporary patients with heart failure.Ilan Goldenberg, Justin Ezekowitz, Christine Albert, Jeffrey D Alexis, Lisa Anderson
Journal of Cardiac Failure. 2025-01-22
Press Mentions
URMC to Lead $27M Heart Failure Medication StudyAugust 13th, 2024- UR Clinical Researchers Get $2.9 Million AwardNovember 15th, 2022
- New DoD Partnership Will Pave the Way for Therapeutic Advances for Chronic DiseasesNovember 2nd, 2022
- Join now to see all
Grant Support
- BCR And Ppargamma As Targets For Transplant ArteriopathyNational Heart, Lung, And Blood Institute2005–2009
- G Proteins As Targets For Transplant ArteriopathyNational Heart, Lung, And Blood Institute1999
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
